🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Monopar Therapeutics Inc.

Monopar Therapeutics Inc. logo
Market Cap: Lowest
Employees: Lowest

Validive

Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for cancer treatment in the United States, with key product candidates including Validive for oral mucositis, Camsirubicin for soft tissue sarcoma, and MNPR-101 related therapeutics.

Tags: Camsirubicin, Validive, biopharmaceutical, cancer treatment, clinical-stage, therapeutics

Website

About | About | About | Leadership | About | Contact

Symbol: MNPR

Recent Price: $23.85

Industry: Biotechnology

CEO: Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc

Sector: Healthcare

Employees: 9

Address: 1000 Skokie Boulevard, Wilmette, IL 60091

Phone: 847 388 0349

Leadership

  • Chandler D. Robinson, MD MBA MSc, Co-Founder, Chief Executive Officer and Board Member
  • Christopher M. Starr, PhD, Co-Founder and Executive Chairman of the Board
  • Andrew Cittadine, MBA, Chief Operating Officer
  • Karthik Radhakrishnan, Chief Financial Officer, Principal Accounting Officer, and Principal Financial Officer
  • Patrice Rioux, MD, PhD., Acting Chief Medical Officer
  • Raymond W. Anderson, MBA, MS, Board Member
  • Michael J. Brown, MSc, Board Member
  • Arthur Klausner, MBA, Board Member
  • Kim R. Tsuchimoto, Board Member

Last updated: 2024-12-31